Position in RDNT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,583
New position
Shares Held
577
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#264
of 327 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Silver Grove Financial Group, Inc. holds $616,077 across 24 Diagnostics & Research names. RDNT ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
289 | $144,893 | |
| 2 | DGX |
Quest Diagnostics Inc
|
539 | $114,241 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
164 | $86,336 | |
| 4 | DHR |
Danaher Corp /De/
|
320 | $60,953 | |
| 5 | RDNT |
RadNet, Inc.
This page
|
577 | $35,583 | |
| 6 | A |
Agilent Technologies, Inc.
|
264 | $35,067 | |
| 7 | LH |
Labcorp Holdings Inc.
|
107 | $29,960 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
21 | $26,827 |
All Filings in RDNT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,583 | 577 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||